The authorities in Italy have granted commercialization approval for GW Pharmaceuticals' Sativex prescription medication. Sativex is indicated for the treatment of moderate to severe spasticity in multiple sclerosis (MS) in patients who ...
Tags: GW Pharmaceutical, Medicine
Forest Laboratories and Almirall have reported positive results from the ACLIdinium/FORMoterol fumarate combination for Investigative use in the treatment of moderate to severe COPD (ACLIFORM/COPD) Phase III study. ACLIFORM/COPD is the ...
Forest Laboratories and Almirall have announced the commercial availability of anticholinergic agent Tudorza Pressair in 400mcg dose strength, in the US pharmacies. The FDA approved long-acting anticholinergic was indicated for the ...
Tags: anticholinergic agent, pharmacies, multidose, Almirall, medicine